Broach Lifecare Hospital Ltd

Broach Lifecare Hospital Ltd announced the resignation of its Chief Financial Officer (CFO), Ms. Urvi Mrunal Hindia. The resignation is effective from the closure of business hours on August 31, 2026, and is attributed to personal reasons. The company acknowledged the resignation on August 25, 2026. This change in key management personnel is disclosed as per SEBI Listing Regulations.

Broach Lifecare Hospital Ltd's Board of Directors approved the audited standalone financial results for the half year and year ended March 31, 2026. The board meeting, held on May 21, 2026, also addressed other business matters as per the agenda. There were no deviations in the utilization of IPO proceeds from October 1, 2025, to March 31, 2026. The company has enclosed the auditor's report with an unmodified opinion and a certificate of correctness of financial results.

Broach Lifecare Hospital Ltd has announced its audited standalone financial results for the half year and year ended March 31, 2026. The results, along with the Auditor's Report, have been submitted under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Key figures from the financial results are included in the filing.

Broach Lifecare Hospital Ltd has released its audited standalone financial results for the half year and financial year ended March 31, 2026. The results, along with the auditor's report, were submitted in compliance with Regulation 30 and 33 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. Revenue from operations for the year ended March 31, 2026, stood at ₹599.47, compared to ₹317.94 for the year ended March 31, 2025.

Broach Lifecare Hospital Ltd filed a statement of deviations and variations of funds raised through its IPO as of March 31, 2026, under Regulation 32(1) of SEBI (LODR) Regulations, 2015. The IPO, which occurred on August 19, 2024, raised ₹402 Lakhs. The report indicates no deviation in the use of funds. The original allocation included ₹262.45 Lakhs for machinery purchase, ₹75.00 Lakhs for a medical tourism portal, ₹19.55 Lakhs for general corporate purposes, and ₹45.00 Lakhs for issue-related expenses. Funds utilized were ₹194.95 Lakhs, ₹48.00 Lakhs, ₹19.55 Lakhs, and ₹45.00 Lakhs respectively, with no reported deviations.

Broach Lifecare Hospital Ltd has scheduled a Board of Directors meeting on May 21, 2026, to consider and approve the audited financial results for the half year and year ended March 31, 2026. The meeting will take place at the company's registered office in Bharuch, Gujarat. The trading window for dealing in the company's shares has been closed since April 1, 2026, and will remain closed until 48 hours after the declaration of the financial results.

Broach Lifecare Hospital Ltd. has announced the closure of the trading window for all designated persons, including directors and promoters, designated employees, and their immediate relatives. The closure is in accordance with the Company's Code of Practices and Procedures for fair Disclosure of Unpublished Price Sensitive Information (UPSI) and the SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will be closed from April 01, 2026, till the completion of 48 hours after the declaration of the Standalone Audited Financial Results for the Half Year and Financial Year ending on March 31, 2026.

Broach Lifecare Hospital Ltd. has approved the unaudited Standalone financial results for the half year ended on September 30, 2025. The company's revenue from operations has increased, and profitability has also seen a significant boost. The company's total income stands at INR 967.67 crores, with total expenses of INR 815.61 crores, resulting in a profit before tax of INR 152.06 crores. The company's net profit for the period stands at INR 111.55 crores.

Broach Lifecare Hospital Ltd. has provided a statement of deviation(s) and variation(s) of funds raised through public issue (IPO) as of September 30, 2025. The company raised funds through an Initial Public Offer (IPO) on August 19, 2024, amounting to 402 Lakhs INR. However, there have been deviations in the use of funds for certain objects. The company has placed an order for Medical Equipment, but the actual utilization differs from the original plan. There is no deviation in the funds utilized for Medical Tourism Portal Development and General Corporate Purposes. The company has not reported any deviation pursuant to a change in terms of a contract or objects, which was approved by the shareholders.

Broach Lifecare Hospital Ltd has appointed M/s. R. M. Hariyani & Co, Chartered Accounts, Bharuch as their internal auditor for the financial year 2025-26. The appointment was made during a board meeting held on November 14, 2025, and is in compliance with the provisions of section 138 of the Companies Act 2013 and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. M/s. R. M. Hariyani & Co has extensive experience in providing comprehensive audits and management consultancy services.